Good Quality Pharmaceutical Raw Ticagrelor Powder Ticagrelor
Price | USD10.00 | USD15.00 | USD20.00 |
Packge | 1kg | 1kg | 1kg |
- Min. Order:1kg
- Supply Ability:1000kg/Month
- Time:2022-06-30
Product Details
- Product NameTICAGRELOR
- CAS No.274693-27-5
- EINECS No.619-540-9
- MFC23H28F2N6O4S
- MW522.57
- AppearanceSolidWhite to Off-White
- density 1.67
- Boiling point 777.6±70.0 °C(Predicted)
- storage temp. Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
- Melting point 138-140°C
Basic Info.
Product Description
Product Name: Ticagrelor
Synonyms: 1,2-Cyclopentanediol, 3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-, (1S,2S,3R,5S)-;Ticagrelor, >=98%;Ticagrelo;Ticargrelor;Brilinta;Possia;Ticagrelor and intermediates;Ticagrelor Standards
CAS: 274693-27-5
MF: C23H28F2N6O4S
MW: 522.57
EINECS: 619-540-9
Boiling point: 777.6±70.0 °C
Description:
Ticagrelor, a new platelet aggregation inhibitor successfully developed by AstraZeneca (U.S.), is the world's first reversible combination orally-administered P2Y12 adenosine diphosphate receptor antagonist.
It is used to reduce cardiovascular death and heart attacks in patients with acute coronary syndrome (ACS.) Rapid onset after oral administration, and can effectively improve symptoms of patients with ACS. Thienopyridines is a reversible P2Y12 inhibitor, so it is particularly applicable towards patients who need to undergo anticoagulant therapy before surgery.
Usage:
Ticagrelor, the first reversible oral P2Y12 receptor antagonist, provides faster, greater, and more consistent ADP-receptor inhibition than Clopidogrel. Used in the treatment of acute coronary syndromes (ACS)
Company Profile Introduction
Recommended supplier
-
VIP1年
- SETV ASRV LLP
- 274693-27-5 Ticagrelor 95-99%
- Inquiry
- 2024-09-11
-
VIP1年
- Aptra Synthesis Pvt Ltd
- 274693-27-5 99%
- Inquiry
- 2024-05-20
-
VIP1年
- Navone Specialties (OPC) Pvt Ltd
- 274693-27-5 Ticagrelor Intermediate 99%
- Inquiry
- 2024-05-02
-
VIP1年
- Raks Pharma Pvt Ltd
- Ticagrelor 274693-27-5 99%
- Inquiry
- 2024-03-27
-
VIP1年
- Amoli Organics Pvt Ltd
- Ticagrelor 98%
- Inquiry
- 2024-03-20
-
VIP1年
- Medec Dragon Private Limited
- Ticagrelor 274693-27-5 99%
- Inquiry
- 2024-03-19
-
VIP1年
- Mylan Laboratories Ltd
- Ticagrelor 98%
- Inquiry
- 2024-03-06
-
VIP1年
- Cohance Lifesciences (Previously RA Chem Pharma Ltd)
- 274693-27-5 98%
- Inquiry
- 2024-02-28
-
VIP1年
- BDR Pharmaceuticals International Pvt Ltd
- 274693-27-5 Ticagrelor 98%
- Inquiry
- 2024-02-24
-
VIP1年
- Sumar Biotech LLP
- Ticagrelor 274693-27-5 98%
- Inquiry
- 2024-02-19
- Since:2022-03-18
- Address: Room 601, Unit 1, Building 1, 188 Xinhuali, North Xinhua Road, Xiangdu District, Xingtai city, Hebei